Vincent Aurentz

Insider Reports History

Location
San Diego, CA
Signature
/s/ David McIntyre, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Vincent Aurentz:

Company Role Class Num Shares Value Price $ Report Date Ownership
Inhibikase Therapeutics, Inc. Director Common Stock 765,895 $1,286,703 $1.68 21 Feb 2025 Direct
Inhibikase Therapeutics, Inc. Director Stock Option (Right to Buy) 108,176 30 Jun 2025 Direct
Longboard Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 22,500 23 May 2024 Direct
ARENA PHARMACEUTICALS INC Executive VP and CBO Common Stock 0 $98.51 11 Mar 2022 Direct
ARENA PHARMACEUTICALS INC Executive VP and CBO Employee Performance Restricted Stock Unit 0 11 Mar 2022 Direct
ARENA PHARMACEUTICALS INC Executive VP and CBO Employee Stock Option (right to buy) 0 11 Mar 2022 Direct
Longboard Pharmaceuticals, Inc. Director Employee Stock Option (right to buy) 0 02 Dec 2024 Direct

Insider Reports Filed by Vincent Aurentz